跳至主要内容
临床试验/CTRI/2025/03/082253
CTRI/2025/03/082253招募中2 期

Efficacy of injectable platelet rich fibrin iPRF with topical 5 percent minoxidil versus microneedling with topical 5 percent minoxidil in male androgenetic alopecia A tertiary care hospital based randomised controlled trial

Dr FARKHANDA SOFI1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年3月14日最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
60
试验地点
1
主要终点
Change in hair density as indicated by hair count/cm2 by trichoscopy.

研究概览

简要总结

As PRP is an established treatment option for androgenetic alopecia, and injectable platelet rich fibrin is a 2 nd generation PRP which has been found to have higher concentration  of growth factors as compared to PRP, we are comparing the efficacy of injectable platelet rich fibrin ( iPRF) vs microneedling (as a standard comparator) in androgenetic alopecia. Patients will undergo monthly sessions of iPRF or microneedling respectively for 6 months and further follow up will be done for a further 6 month period.  Moreover, minoxidil 5 % will be applied by patients of  both the arms of the trial twice daily. We will assess hair count by trichoscopy at 0,6 months and 12 months.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 50.00 Year(s)(—)
性别
Male

入选标准

  • Androgenetic alopecia Norwood Hamilton grade III- V No history of treatment with PRP or Finasteride in the past 6 months.
  • No history of minoxidil oral or topical for at least 2 months prior to study.

排除标准

  • Active scalp infections or skin diseases (psoriasis, eczema).
  • Known hypersensitivity to minoxidil or any other study components.
  • Prior hair transplantation.
  • Any coagulation disorder or thrombocytopenia.

结局指标

主要结局

Change in hair density as indicated by hair count/cm2 by trichoscopy.

时间窗: At 0, 6 and 12 months.

次要结局

  • Difference between the response of injectable platelet rich fibrin (iPRF) and microneedling in different stages of androgenetic alopecia.(maintainence period of response achieved for a further 6 month follow up period.)

研究者

发起方
Dr FARKHANDA SOFI
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Farkhanda Sofi

ALL INDIA INSTITUTE OF MEDICAL SCIENCES GORAKHPUR

研究点 (1)

Loading locations...

相似试验